Analysis of Biomarkers From Patients With Chorioretinal Diseases

计划入组 100 人 · 首次发布于 2014 年 1 月 3 日

sing N-of-1 tests to identify responders to melatonin for sleep disturbance in Parkinson’s Disease

计划入组 44 人

Effect of three cueing devices (visual, auditory, and vibration) for people with Parkinson’s disease with freezing of gait difficulties

计划入组 25 人

neuroprotectants (Parkinson’s disease)

Parkinson’s Disease(Nitrase)

drug candidate (Parkinson’s disease)

RECORDATI RARE DISEASES

France

BAMRASNARADURA INFECTIOUS DISEASES INSTITUTE

Thailand

ANRS, Emerging Infectious Diseases

France

Coya Therapeutics Advances Treg-Enhancing Therapy for ALS into Phase 2b Trial

Annovis Bio to Present Buntanetap Alzheimer's Research at CTAD 2024

AskBio's AB-1005 Gene Therapy for Parkinson’s Disease Meets Primary Endpoint in Phase Ib Trial